Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal in Heart Transplant Recipients: A Randomized Trial von Andreassen, A. K., Andersson, B., Gustafsson, F., Eiskjær, H., Rådegran, G., Gude, E., Jansson, K., Solbu, D., Sigurdardottir, V., Arora, S., Dellgren, G., Gullestad, L.

Volltext

(20) - Scandinavian Heart Transplant Everolimus De Novo Study With Early Calcineurin Inhibitors Avoidance (Schedule): Results After 6 Years of Follow-up von Andreassen, A.K.

Volltext

Predictors for Peak Oxygen Uptake in De Novo Heart Transplant Recipients (the HITTS Study) von Rolid, K, Yardley, M, Authen, A.R, Grov, I, Kunszt, M.R, Bjørkelund, E, Gude, E, Andreassen, A.K, Gullestad, L, Nytrøen, K

Volltext

Echocardiographic Evidence for Right Ventricular Functional Improvement After Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension von Broch, K, Ragnarsson, A, Andersen, R, Gude, E, Fiane, A, Andreassen, J, Aakhus, S, Andreassen, A.K

Volltext

Cognitive function in long-term survivors after heart transplantation von Bürker, B.S, Gude, E, Gullestad, L, Relbo Authen, A, Grov, I, Andreassen, A.K, Havik, O.E, Fiane, A.E, Hebold Haraldsen, I.R, Malt, U.F, Andersson, S

Volltext

Development of Hypertension in Heart Transplant Recipients Treated With Everolimus Vompared to a Cyclosporine Based Regimen von Andreassen, A.K, Eiskjær, H, Gude, E, Mølbak, D, Stueflotten, W, Gullestad, L

Volltext

Psychiatric Morbidity in De Novo Heart Transplant Recipients on Everolimus-Based Immunosuppression von Bürker, B.S, Malt, U.F, Gude, E, Gullestad, L, Relbo, A, Grov, I, Andreassen, A.K, Fiane, A.E, Haraldsen, I.R

Volltext

Coronary Physiology Assessment After Heart Transplantation von Solberg, O, Stavem, K, Ragnarsson, A, Gude, E, Andreassen, A.K, Gullestad, L, Karason, K, Ioanes, D, Aaberge, L

Volltext

Long-term Effect on Albuminuria and Glomerular Filtration Rate of a Calcineurin Inhibitor-Free Everolimus Based Immunosuppressive Regimen after Heart Transplantation von Nelson, L.M, Andreassen, A.K, Andersson, B, Gude, E, Eiskjær, H, Raadegran, G, Dellgren, G, Gullestad, L, Gustafsson, F

Volltext

Maintained Cardiac Reserve in Heart Transplant Patients During Early Calcineurin Inhibitor Avoidance: A Substudy of a Randomised Controlled Trial (SCHEDULE Trial) von Bartfay, S, Gullestad, L, Sigurdardottir, V, Andreassen, A.K, Gude, E, Andersson, B

Volltext

Cognitive Functioning Among De Novo Heart Transplant Recipients on Everolimus-Based Immunosuppression von Bürker, B.S, Andersson, S, Gullestad, L, Gude, E, Relbo, A, Grov, I, Malt, U.F, Andreassen, A.K, Fiane, A.E, Haraldsen, I.H

Volltext

The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Allograft Vasculopathy Assessed by Virtual Histology: Results of the SCHEDULE Trial von Arora, S, Solberg, O, Gustafsson, F, Karason, K, Eiskjær, H, Bøtker, H.E, Rådegran, G, Dellgren, G, Ioanes, D, Gude, E, Solbu, D, Andreassen, A.K, Gullestad, L

Volltext

Three Year Follow Up of the Randomized SCHEDULE Trial With Everolimus Initiation and Early Withdrawal of Calcineurin Inhibitor Therapy in De Novo Heart Transplant Recipients - A Mu... von Andreassen, A.K, Andersson, B, Gustafsson, F, Eiskjær, H, Rådegran, G, Gude, E, Jansson, K, Solbu, D, Karason, K, Arora, S, Dellgren, G, Gullestad, l

Volltext

Everolimus and Cyclosporine Equally Improve QoL in De Novo Heart Transplanted Patients: The Results of a Randomized Controlled Trial (SCHEDULE Trial) von Relbo, A, Grov, I, Andersson, B, Gustafsson, F, Eiskjær, H, Rådegran, G, Gude, E, Jansson, K, Solbu, D, Sigurdardottir, V, Arora, S, Dellgren, G, Andreassen, A.K, Gullestad, L

Volltext

(1088) - The Association Between Body Mass Index, Exercise Capacity, and Health-Related Quality of Life in Heart Transplant Recipients von Broch, K., Holmen, S., Rolid, K., Englund, K., Østby, C.M., Gude, E., Andreassen, A.K., Gullestad, L.

Volltext

Cognitive Function in Iron Deficient Heart Transplant Recipients Receiving Intravenous Iron Supplement: A Prespecified Secondary Endpoint in the Randomized Ironic Trial von Brautaset Englund, K.V., Oestby, C.M., Rolid, K., Gude, E., Andreassen, A.K., Gullestad, L., Broch, K.

Volltext

Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three‐Year Results From the Randomized SCHEDULE Study von Andreassen, A. K., Andersson, B., Gustafsson, F., Eiskjær, H., Rådegran, G., Gude, E., Jansson, K., Solbu, D., Karason, K., Arora, S., Dellgren, G., Gullestad, L.

Volltext

529: Simultaneous Measurement of Serum N-Terminal Brain Natriuretic Peptide and Troponin T in Risk Assessment of Pateints with Precapillary Pulmonary Hypertension von Andreassen, A.K, Arora, S, Gude, E, Solberg, O.G, Wergeland, R

Volltext

Health Related Quality of Life in Iron Deficient Heart Transplant Recipients Receiving Intravenous Iron Supplement: A Prespecified Secondary Endpoint in the IronIC Trial von Englund, K. Brautaset, Oestby, C.M., Rolid, K., Gude, E., Andreassen, A.K., Gullestad, L., Broch, K.

Volltext

Pulmonary Endarterectomy (PEA) vs. Balloon Pulmonary Angioplasty (BPA) in Chronic Thrombo-Embolic Pulmonary Hypertension (CTEPH): Comparison of Improvements in Hemodynamics and Fun... von Ravnestad, H., Andersen, R., Birkeland, S., Svalebjørg, M., Lingaas, P.S., Gude, E., Gullestad, L.L., Broch, K., Andreassen, A.K.

Volltext